INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise · 10b5-1 plan
M$19K
80.7K sh
Jun 15, 2026
Page 683 of 1737
← PrevNext →
Jun 16, 2026
traded Jun 15, 2026
+1d
SEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise · 10b5-1 plan
M—
80.7K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
AE
Alvarez Divo Carlos EduardoDirector
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
10.7K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$439K
555.6K sh
Jun 16, 2026Jun 16, 2026
traded Jun 16, 2026
+0dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
555.6K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
2,520 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
250 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
FJ
Fiedler-Kelly JillPresident, Services Solutions
SLPSimulations Plus, Inc.
Option exercise · 10b5-1 plan
M—
1,050 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
FJ
Fiedler-Kelly JillPresident, Services Solutions
SLPSimulations Plus, Inc.
Option exercise · 10b5-1 plan
M$11K
1,050 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
555.6K sh
Jun 16, 2026Jun 16, 2026
traded Jun 16, 2026
+0dSEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$439K
555.6K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M—
1,453 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M$1,250
1,453 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
250 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M$3,440
4,000 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M—
4,000 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
TY
Tan Anthony Ping YeowDirector, Chief Executive Officer
GRABGrab Holdings Ltd
Derivative conversion · 10b5-1 plan
C—
800.0K sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC Form 4

Evidence

54
DW
Da Cunha Gustavo WerneckCEO and Board Member
GGBGERDAU S.A.
Open-market purchase
BUY$782K
165.2K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

52
CM
Clark Benjamin M.EVP - Global Supply Chain
ECLECOLAB INC.
Open-market purchase
BUY$264K
1,000 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

51
RA
Rosenberg AaronChief Financial Officer
ONCBeOne Medicines Ltd.
Open-market sale
SELL$163K
631 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

50
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$886K
3,461 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

50
KJ
Kuczinski Anthony JDirector
RYANRYAN SPECIALTY HOLDINGS, INC.
Open-market purchase
BUY$87K
2,500 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

50
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$765K
3,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

47
DC
Davis Todd CDirector
PTHSPelthos Therapeutics Inc.
Open-market purchase
BUY$986K
35.4K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

47
WL
Wang LaiPresident, Global Head of R&D
ONCBeOne Medicines Ltd.
Open-market sale
SELL$197K
756 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

44
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$110K
428 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

43
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$2.67M
23.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

43
CK
Cohn Charles K.Director, Chief Executive Officer, 10% Owner
NRDYNerdy Inc.
Open-market purchase
BUY$251K
251.1K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

41
FF
Famularo Adam FrancisDirector
MVBFMVB FINANCIAL CORP
Open-market purchase
BUY—
1,835 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

40
AL
Anderson Dyaarl Lee Jr.Chief Commercial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$9,525
4,739 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

40
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$878K
7,500 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

39
AG
Abbott Paul GDirector, Chief Executive Officer
GBTGGlobal Business Travel Group, Inc.
Open-market sale
SELL$5.37M
574.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

37
BS
Bulis Veronica SanchezVP, Corporate Controller
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$4,103
217 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

37
HJ
Hill Stephen J.Chief Operating Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$1,684
89 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

37
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$2,460
130 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

37
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$445K
3,418 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

36
RT
Romer John TimothyDirector
GVAGRANITE CONSTRUCTION INC
Open-market purchase
BUY$53K
375 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

36
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$524K
4,449 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence